Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Nature Communications|May 13, 2020
Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancerJennifer Y Ge, Shaokun Shu, Mijung Kwon, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2017
Embryonic transcription factor SOX9 drives breast cancer endocrine resistanceRinath Jeselsohn, MacIntosh Cornwell, Matthew Pun, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2024
Somatic Activating ESR1 Mutation in an Aggressive ProlactinomaTiciana Paes, Jacobo Buelvas Mebarak, John C Magnotto, et al.
Cancer Cell|November 20, 2020
Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid LeukemiaShruti Bhatt, Marissa S Pioso, Elyse Anne Olesinski, et al.
Nature Genetics|August 22, 2025
Tamoxifen induces PI3K activation in uterine cancerKirsten Kübler, Agostina Nardone, Shankara Anand, et al.
Genome Medicine|June 27, 2026
ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistanceCristina Guarducci, Daniel Abravanel, Douglas Russo, et al.
Nature Medicine|July 25, 2018
Tumor innate immunity primed by specific interferon-stimulated endogenous retrovirusesIsrael Cañadas, Rohit Thummalapalli, Jong Wook Kim, et al.
Science Translational Medicine|September 13, 2021
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of <i>EGFR</i>-mutant lung cancerPınar Özden Eser, Raymond M Paranal, Jieun Son, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2024
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal CancerHarshabad Singh, Pranshu Sahgal, Kevin Kapner, et al.
Pageof 3